motion to transfer venue

By Memorandum Opinion entered by The Honorable Maryellen Noreika in ANI Pharmaceuticals, Inc. v. Method Pharmaceuticals, LLC et al., Civil Action No. 17-1097-MN (D.Del. January 11, 2019), the Court granted-in-part Defendants’ Motion to Dismiss under Federal Rule of Civil Procedure 12(b)(2) or, in the Alternative, Transfer Venue to the extent that it sought to

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Genentech, Inc. et al. v. Amgen Inc., Civil Action No. 17-1407-GMS (D.Del. January 22, 2018), the Court denied defendant Amgen Inc.’s motion to transfer two patent infringement actions from the United States District Court for the District of Delaware to the United States

By Memorandum Order entered by The Honorable Leonard P. Stark in Javelin Pharmaceuticals, Inc. et al. v. Mylan Laboratories Limited et al., Civil Action No. 16-224-LPS (D.Del., December 1, 2017), the Court denied without prejudice the motion to dismiss for improper venue or, in the alternative, to transfer venue to the Northern District of

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Koniklijke Philips N.V. v. HTC Corp., Civil Action No. 15-1125-GMS (D.Del. July 18, 2017), the Court denied Defendants’ Joint Motion to Transfer Venue which sought to transfer venue of the patent infringement action to either the Northern District of California, the Western District

By Memorandum Order entered by The Honorable Gregory M. Sleet in Blackbird Tech LLC d/b/a Blackbird Technologies v. TuffStuff Fitness et al., Civil Action No. 16-733-GMS (D.Del. April 27, 2017), the Court granted the motion to transfer venue to the United States District Court for the Central District of California of defendant TuffStuff Fitness

By Memorandum Order entered by The Honorable Sue L. Robinson in Par Pharmaceutical, Inc., et al. v. Breckenridge Pharmaceutical, Inc., et al., Civil Action No. 15-486-SLR (D.Del., September 10, 2015), the Court denied the motion to transfer venue filed by defendants Twi Pharmaceuticals, Inc. and Twi Pharmaceuticals USA, Inc. after expressly disagreeing with defendants

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in AT&T Intellectual Property I, L.P. v. Cox Communications, Inc., et al., Civil Action No. 14-1106-GMS (D.Del., July 9, 2015), the Court denied the motion to transfer of defendants after finding that defendant parent company had made prior inconsistent representations to the Court about

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Memory Integrity, LLC v. Intel Corporation, Civil Action No. 13-1804-GMS (D.Del., February 13, 2015), the Court granted the motion of Defendant Intel Corporation (‘Intel”) to transfer venue of the patent infringement action to the District of Oregon pursuant to 28 U.S.C. § 1404(a). 

By Memorandum Order entered by The Honorable Leonard P. Stark in Selene Communication Technologies, LLC v. Trend Micro Inc., et al., Civil Action No. 14-435-LPS (D.Del., January 16, 2015), the Court granted defendants’ motion to transfer the action to the United States District Court for the Northern District of California (“Northern District”), pursuant to

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Ithaca Ventures k.s., et al. v. Nintendo of America Inc., et al., C.A. No. 13-824-GMS (D.Del., September 25, 2014), the Court granted Nintendo’s motion to transfer the patent infringement action to the Western District of Washington pursuant to 28 U.S.C. § 1404(a). In